Literature DB >> 8739846

The motor performance test series in Parkinson's disease is influenced by depression.

W Kuhn1, N Heye, T Müller, P Kraus, P Klotz, B Friedrich, F L Welter, H Przuntek.   

Abstract

The Motor Performance Test Series (MPTS) is widely used for treatment control in Parkinson's disease (PD). To elucidate the possible influence of depression on the fine motor skills in PD, 54 patients with idiopathic PD were investigated with the MPTS. 27 patients with major intensity of depression were compared to 27 age and motor disability matched patients with minor symptoms of depression, evaluated by the Zung depression scale. As determined by the subtest aiming, a significant lower ability for precise, quick complex arm-hand movements in depressed Parkinsonian patients was found. This result may be explained partly by motivation deficits in depressed patients with PD. On the other hand impairment of special motor loops including frontal lobe projections to specific thalamic subnuclei or to the caudate nucleus may cause disturbances of the subtest aiming in depressed Parkinsonian patients. On the basis of these findings impaired aiming may be explained by diminished ability for complex, semivoluntary movements in depressive Parkinsonian patients. The influence of psychiatric comorbidity on MPTS subtest aiming has to be considered in further therapy studies using evaluation of motor deficits by MPTS.

Entities:  

Mesh:

Year:  1996        PMID: 8739846     DOI: 10.1007/BF01271246

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  16 in total

1.  Quantification of motor deficit in Parkinson's disease with a motor performance test series.

Authors:  M M Pinter; R J Helscher; C O Nasel; E Riedl; G Schnaberth
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1992

2.  Assessment of symptoms of Parkinson's disease by apparative methods.

Authors:  P H Kraus; P Klotz; A Fischer; H Przuntek
Journal:  J Neural Transm Suppl       Date:  1987

3.  Cognitive impairments and depression in Parkinson's disease: a follow up study.

Authors:  S E Starkstein; P L Bolduc; H S Mayberg; T J Preziosi; R G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-07       Impact factor: 10.154

4.  Frontal dysfunction in early Parkinson's disease.

Authors:  E Farina; S F Cappa; M Polimeni; E Magni; M Canesi; A Zecchinelli; G Scarlato; C Mariani
Journal:  Acta Neurol Scand       Date:  1994-07       Impact factor: 3.209

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Psychomotor slowing and subcortical-type dysfunction in depression.

Authors:  R P Hart; J A Kwentus
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

7.  Effort and cognition in depression.

Authors:  R M Cohen; H Weingartner; S A Smallberg; D Pickar; D L Murphy
Journal:  Arch Gen Psychiatry       Date:  1982-05

8.  Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.

Authors:  E D Playford; I H Jenkins; R E Passingham; J Nutt; R S Frackowiak; D J Brooks
Journal:  Ann Neurol       Date:  1992-08       Impact factor: 10.422

9.  Relationship of motor symptoms, intellectual impairment, and depression in Parkinson's disease.

Authors:  S J Huber; G W Paulson; E C Shuttleworth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

10.  Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression.

Authors:  E Rubin; H A Sackeim; I Prohovnik; J R Moeller; D B Schnur; S Mukherjee
Journal:  Psychiatry Res       Date:  1995-05-31       Impact factor: 3.222

View more
  9 in total

1.  Multimodal MRI evaluation of parkinsonian limbic pathologies.

Authors:  Ernest W Wang; Guangwei Du; Mechelle M Lewis; Eun-Young Lee; Sol De Jesus; Sangam Kanekar; Lan Kong; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2019-01-16       Impact factor: 4.673

2.  Changes of hand preference in Parkinson's disease.

Authors:  Jan Štochl; Tim J Croudace; Hana Brožová; Jiří Klempíř; Jan Roth; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2012-01-10       Impact factor: 3.575

3.  Clinical correlates of depressive symptoms in familial Parkinson's disease.

Authors:  Nathan Pankratz; Karen S Marder; Cheryl A Halter; Alice Rudolph; Cliff W Shults; William C Nichols; Tatiana Foroud
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

4.  Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.

Authors:  Kenn Freddy Pedersen; Guido Alves; Kolbjørn Brønnick; Dag Aarsland; Ole-Bjørn Tysnes; Jan Petter Larsen
Journal:  J Neurol       Date:  2009-08-25       Impact factor: 4.849

5.  The impact of depressive symptoms in early Parkinson disease.

Authors:  B Ravina; R Camicioli; P G Como; L Marsh; J Jankovic; D Weintraub; J Elm
Journal:  Neurology       Date:  2007-06-20       Impact factor: 9.910

6.  The diagnosis and treatment of depression in Parkinson's disease.

Authors:  William M McDonald; Paul E Holtzheimer; Eve H Byrd
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.972

7.  Altered directional connectivity between emotion network and motor network in Parkinson's disease with depression.

Authors:  Peipeng Liang; Gopikrishna Deshpande; Sinan Zhao; Jiangtao Liu; Xiaoping Hu; Kuncheng Li
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Abnormal baseline brain activity in non-depressed Parkinson's disease and depressed Parkinson's disease: a resting-state functional magnetic resonance imaging study.

Authors:  Xuyun Wen; Xia Wu; Jiangtao Liu; Ke Li; Li Yao
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

9.  Influence of depressive symptoms on dopaminergic treatment of Parkinson's disease.

Authors:  Alexandru Hanganu; Clotilde Degroot; Oury Monchi; Christophe Bedetti; Béatriz Mejia-Constain; Anne-Louise Lafontaine; Sylvain Chouinard; Marie-Andrée Bruneau
Journal:  Front Neurol       Date:  2014-09-25       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.